Literature DB >> 7629240

Comparison of markers for bone formation and resorption in premenopausal and postmenopausal subjects, and osteoporosis patients.

K Kushida1, M Takahashi, K Kawana, T Inoue.   

Abstract

Recently, the biochemical markers for bone metabolism have been developed and are expected to reflect the minor change of bone turnover. We compared bone formation markers: alkaline phosphatase-(Alp), bone gla-protein(BGP), carboxy-terminal propeptide of type I collagen(PICP); and bone resorption markers: carboxy-terminal telopeptide of type I collagen(ICTP), pyridinoline(Pyr), deoxypyridinoline(Dpyr) to see if they reflected the effects of aging and menopause in 95 premenopausal and 66 postmenopausal healthy subjects. We also compared the bone turnover in 29 vertebral osteoporosis patients. All markers except ICTP significantly increased with age in the healthy subjects. Alp, BGP, PICP, Pyr, and Dpyr were significantly higher in the postmenopausal group than in the premenopausal group. BGP, Pyr, and Dpyr in premenopausal subjects in their 50s were already significantly increased compared with BGP, Pyr, and Dpyr in premenopausal subjects in their 30s and 40s. To evaluate the discrimination power of the six markers in the postmenopausal subjects and in patients with osteoporosis, the z scores of six markers were calculated against the premenopausal group. z-scores of bone resorption markers(ICTP, Pyr, and Dpyr) were much higher than those of bone formation markers (Alp, BGP, and PICP) in patients with osteoporosis, even though z-scores of bone resorption markers were similar to those of bone formation markers in postmenopausal subjects. In conclusion, Alp, BGP, PICP, Pyr, and Dpyr had good performance in postmenopausal status. Resorption markers increased more than formation markers in osteoporosis subjects, and the bone turnover in osteoporosis subjects was more uncoupled than in postmenopausal subjects.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7629240     DOI: 10.1210/jcem.80.8.7629240

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  23 in total

1.  Lycopene consumption decreases oxidative stress and bone resorption markers in postmenopausal women.

Authors:  L G Rao; E S Mackinnon; R G Josse; T M Murray; A Strauss; A V Rao
Journal:  Osteoporos Int       Date:  2006-08-29       Impact factor: 4.507

2.  Vertebral and metacarpal morphometry as indicators of nutritional improvement.

Authors:  M Revilla; E Fraile; F Aguado; E R Hermandez; L F Villa; H Rico
Journal:  Clin Rheumatol       Date:  1997-05       Impact factor: 2.980

3.  Changes in bone resorption across the menopause transition: effects of reproductive hormones, body size, and ethnicity.

Authors:  MaryFran R Sowers; Huiyong Zheng; Gail A Greendale; Robert M Neer; Jane A Cauley; Jayne Ellis; Sarah Johnson; Joel S Finkelstein
Journal:  J Clin Endocrinol Metab       Date:  2013-05-10       Impact factor: 5.958

4.  Evaluation of bone turnover in postmenopause, vertebral fracture, and hip fracture using biochemical markers for bone formation and resorption.

Authors:  M Takahashi; K Kushida; H Hoshino; T Ohishi; T Inoue
Journal:  J Endocrinol Invest       Date:  1997-03       Impact factor: 4.256

5.  Age- and sex-specific concentrations of bone remodeling markers in healthy Indian adults with and without vitamin D deficiency.

Authors:  Rimesh Pal; Anshita Aggarwal; Naresh Sachdeva; Sant Ram; Abhilasha Garg; Anil Bhansali; Sanjay Kumar Bhadada
Journal:  Arch Osteoporos       Date:  2021-01-07       Impact factor: 2.617

6.  Reproduction Differentially Affects Trabecular Bone Depending on Its Mechanical Versus Metabolic Role.

Authors:  Chantal M J de Bakker; Wei-Ju Tseng; Yihan Li; Hongbo Zhao; Allison R Altman-Singles; Yonghoon Jeong; Juhanna Robberts; Lin Han; Do-Gyoon Kim; X Sherry Liu
Journal:  J Biomech Eng       Date:  2017-11-01       Impact factor: 2.097

7.  Loss of alveolar bone density in postmenopausal, osteopenic women is associated with circulating levels of gelatinases.

Authors:  David M Thompson; Hsi-Ming Lee; Julie A Stoner; Lorne M Golub; Pirkka V Nummikoski; Jeffrey B Payne
Journal:  J Periodontal Res       Date:  2019-04-29       Impact factor: 4.419

8.  Increased cancellous bone in the femoral neck of patients with coxarthrosis (hip osteoarthritis): a positive remodeling imbalance favoring bone formation.

Authors:  G R Jordan; N Loveridge; J Power; M T Clarke; J Reeve
Journal:  Osteoporos Int       Date:  2003-03-05       Impact factor: 4.507

9.  Bone effects of rosiglitazone in HIV-infected patients with lipoatrophy.

Authors:  Allison C Ross; Corrilynn O Hileman; Todd T Brown; Neal Fedarko; Norma Storer; Danielle Labbato; Grace A McComsey
Journal:  HIV Clin Trials       Date:  2012 Jul-Aug

10.  Progesterone and bone: actions promoting bone health in women.

Authors:  Vanadin Seifert-Klauss; Jerilynn C Prior
Journal:  J Osteoporos       Date:  2010-10-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.